Severe necrotizing myopathy after COVID-19 vaccine with BNT162b2 and regimen with ipilimumab plus nivolumab in a patient with advanced melanoma진행성 흑색종 환자에서 BNT162b2를 사용한 COVID-19 백신 및 이필리무맙 + 니볼루맙 요법 후 중증 괴사성 근병증 Published on 2022-02-012022-09-12 Journal: Journal of the European Academy of Dermatology and [키워드] BNT162b2 COVID-19 vaccine Ipilimumab Melanoma nivolumab Patient regimen [저자] M Blaise, F Rocher, H Spittler, A Sanchez, E Lanteri, L Coco, A Puma, A Martel, G Gonfrier, T Passeron, H Montaudié [Category] COVID19(2023년), MERS, SARS, 진단, PMC URL [DOI] 10.1111/jdv.17760 [Article Type] Article [Source] PMC All Keywords 【제목키워드】 COVID-19 vaccine, BNT162b2, Patient, Melanoma, nivolumab, regimen, Ipilimumab,